Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study

  • J. C. CorredoiraEmail author
  • M. P. Alonso
  • J. F. García
  • E. Casariego
  • A. Coira
  • A. Rodriguez
  • J. Pita
  • C. Louzao
  • B. Pombo
  • M. J. López
  • J. Varela


The aim of this study was to determine the clinical significance of Streptococcus salivarius isolates recovered from blood cultures and compare them with isolates of Streptococcus bovis biotypes I and II. Seventeen of the 52 (32%) S. salivarius isolates recovered were considered clinically significant, compared with 62 of the 64 (97%) S. bovis isolates (p<0.0001). Bacteremia caused by S. salivarius occurred mostly in patients who showed relevant disruption of the mucous membranes and/or serious underlying diseases. Patients with S. salivarius bacteremia were younger than those with S. bovis bacteremia (57 vs. 67 years; p<0.01). Patients with S. salivarius bacteremia and patients with S. bovis II bacteremia had similar rates of endocarditis, colon tumors, and noncolon cancer. On the other hand, when compared with S. bovis I bacteremia, S. salivarius bacteremia was associated with lower rates of endocarditis (18% vs. 74%, respectively) (p<0.01) and colon tumors (0% vs. 57%, respectively) (p<0.005) and higher rates of noncolon cancer (53% vs. 9.5%, respectively) (p<0.01). Bacteremia caused by S. bovis II had a hepatobiliary origin in 50% of the patients, while, in contrast, that due to S. salivarius or S. bovis I was less frequently associated with a hepatobiliary origin (12% and 5%, respectively) (p<0.00001). The rate of penicillin resistance was 31% among S. salivarius isolates and 0% among S. bovis isolates (p<0.0001). In conclusion, the clinical characteristics of S. salivarius bacteremia and S. bovis II bacteremia are similar, and the isolation of S. salivarius in blood should not be systematically regarded as contamination.


Blood Culture Endocarditis Positive Blood Culture Mucosal Disruption Blood Isolate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



The authors thank Javier Ariza for his comments and his review of the manuscript. This work was supported in part by a grant from the Public Health Service of Galicia, Spain (PGDIT.00.SAN.00007-PR)


  1. 1.
    Whiley R, Beighton D (1998) Current classification of the oral streptococci. Oral Microbiol Immunol 13:195–216Google Scholar
  2. 2.
    Sanders CC, Sanders Jr WE (1982) Enocin: an antibiotic produced by Streptococcus salivarius that may contribute to protection against infections due to group A streptococci. J Infect Dis 146:683–690Google Scholar
  3. 3.
    Facklam R (2002) What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 15:613–630Google Scholar
  4. 4.
    Ruoff K, Ferraro M, Holden J, Kunz L (1984) Identification of Streptococcus bovis and Streptococcus salivarius in clinical laboratories. J Clin Microbiol 20:223–226Google Scholar
  5. 5.
    Coykendall A, Gustafson K (1985) Deoxyribonucleic acid hybridizations among strains of Streptococcus salivarius and Streptococcus bovis. Int J Syst Bacteriol 35:274–280Google Scholar
  6. 6.
    Ruoff K, Miller S, Garner C, Ferraro M, Calderwood S (1989) Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J Clin Microbiol 27:305–308Google Scholar
  7. 7.
    Schlegel L, Grimont F, Ageron E, Grimont P, Bouset A (2003) Reappraisal of the taxonomy of the Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov and S. gallolyticus subsp. pasteurianus subsp. nov. Int J Syst Evol Microbiol 53:631–645Google Scholar
  8. 8.
    Brennan R, Durack D (1984) The viridans streptococci in perspective. In: Remington JS, Swartz MN (ed) Current clinical topics in infectious diseases, vol. 5. McGraw Hill, New York, pp 253–289Google Scholar
  9. 9.
    Swenson F, Rubin S (1982) Clinical significance of viridans streptococci isolated from blood cultures. J Clin Microbiol 15:725–727Google Scholar
  10. 10.
    Ruiz M, Soriano F (1994) Significado clínico de la bacteriemia por estreptococos del grupo viridans. Enf Infecc Microbiol Clin 12:426–432Google Scholar
  11. 11.
    Cabellos C, Viladrich P, Corredoira J, Verdaguer R, Ariza J, Gudiol F (1999) Streptococcal meningitis in adult patients: current epidemiology and clinical spectrum. Clin Infect Dis 28:1104–1108Google Scholar
  12. 12.
    Heidemann D, Dunns S, Haimamn M (1989) S. salivarius endophthalmitis from contaminated donor cornea after keratoplasty. Am J Ophtalmol 107:429–430Google Scholar
  13. 13.
    Bouvier M, Lejerine E, Rouillat M, Wolfrom C (1979) Osteite femorale avec isolement in situ d’un Streptococcus salivarius. Nouv Presse Med 8:3899–3900Google Scholar
  14. 14.
    Romero M, Larraona JL (1999) Pancreatic abscess due to Streptococcus salivarius after dental manipulation. Am J Gastroenterol 94:1987–1988Google Scholar
  15. 15.
    Cunliff N, Jacob A (1997) Streptococcus vestibularis bacteraemia. J Infect 34:85Google Scholar
  16. 16.
    Partridge S (2000) Prosthetic valve endocarditis due to Streptococcus vestibularis. J Infect 41:284–285Google Scholar
  17. 17.
    Doyuk E, Ormerod O, Bowler I (2002) Native valve endocarditis due to Streptococcus vestibularis and Streptococcus oralis. J Infect 45:39–41Google Scholar
  18. 18.
    Avada A, van der Auwera P, Meunier F, Daneau D, Klasterky J (1992) Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Dis 15:33–48Google Scholar
  19. 19.
    Hoecker JL, Pickering D, Groschel D, Kohl S (1978) Streptococcus salivarius sepsis in children with malignancies. J Pediatr 92:337–338Google Scholar
  20. 20.
    Carratalá J, Alcaide F, Fernández-Sevilla A, Corbella X, Liñares J, Gudiol F (1995) Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. Clin Infect Dis 20:1169–1173Google Scholar
  21. 21.
    Ruoff K, Whiley R, Beighton D (2003) Streptococcus. In: Murray P, Baron E, Pfaller M, Yolken R(eds) Manual of clinical microbiology. ASM Press, Washington DC, pp 405–421Google Scholar
  22. 22.
    Coykendall A (1989) Classification and identification of the viridans streptococci. Clin Microbiol Rev 2:315–325Google Scholar
  23. 23.
    National Committee for Clinical Laboratory Standards (2000) Performance standards for antimicrobial disk susceptibility testing. Approved standard M2-A7. NCCLS, Wayne, PAGoogle Scholar
  24. 24.
    National Committee for Clinical Laboratory Standards (2002) Performance standards for antimicrobial susceptibility testing. Informational supplement M100-S12. NCCLS, Wayne, PAGoogle Scholar
  25. 25.
    Weinstein M, Towns M, Quartey S, Mirrett S, Reimer L, Parmigiany G (1996) The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24:584–602Google Scholar
  26. 26.
    Durack D, Lukes A, Bright D (1994) New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 96:200–209Google Scholar
  27. 27.
    Facklam R (1997) Physiological differentiation of viridans streptococci. J Clin Microbiol 5:184–201Google Scholar
  28. 28.
    Parker M, Ball L (1976) Streptococci and aerococci associated with systemic infection in man. J Med Microbiol 9:275–302Google Scholar
  29. 29.
    Watanakunakorn C, Pantelakis J (1993) Alfa-hemolytic streptococcal bacteremia: a review of 203 episodes during 1980–1991. Scand J Infect Dis 25:403–408Google Scholar
  30. 30.
    Bryan C (1989) Clinical implications of positive blood cultures. Clin Microbiol Rev 2:329-353Google Scholar
  31. 31.
    Guerrero AL, Guerrero A (2002) Meningitis por Streptococcus salivarius y fístula espontánea: a propósito de un caso. Rev Neurol 35:799–800Google Scholar
  32. 32.
    Lark R, Chenoweth C, Saint S, Zemencuk J, Lipsky B, Plorde J (2000) Four-year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome. Diag Microbiol Infect Dis 38:131–140Google Scholar
  33. 33.
    Klein R, Recco R, Catalano M, Edberg S, Casey J, Steigbigel N (1977) Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 297:800–802Google Scholar
  34. 34.
    Roses D, Richman H, Localio S (1974) Bacterial endocarditis associated with colorectal carcinoma. Ann Surg 179:190–191Google Scholar
  35. 35.
    Alcaide F, Liñares J, Pallarés R, Carratalá J, Benitez M, Gudiol F, Martín R (1995) In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother 39:2243–2247Google Scholar
  36. 36.
    Doern G, Ferraro M, Brueggemann A, Ruoff K (1996) Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 44:891–894Google Scholar
  37. 37.
    Tuohy M, Washington J (1997) Antimicrobial susceptibility of viridans group streptococci. Diagn Microbiol Infect Dis 29:277–280Google Scholar
  38. 38.
    Carratalá J, Gudiol F (1995) Life-threatening infections due to penicillin-resistant viridans streptococci. Curr Opin Infect Dis 8:123–126Google Scholar
  39. 39.
    Dajani AS, Tauber KA, Wilson W, Bolger A, Bayer A, Ferrieri P (1997) Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 277:1794–1801Google Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • J. C. Corredoira
    • 1
    Email author
  • M. P. Alonso
    • 2
  • J. F. García
    • 3
  • E. Casariego
    • 1
  • A. Coira
    • 2
  • A. Rodriguez
    • 2
  • J. Pita
    • 2
  • C. Louzao
    • 1
  • B. Pombo
    • 1
  • M. J. López
    • 1
  • J. Varela
    • 1
  1. 1.Infectious Disease UnitHospital Xeral-CaldeLugoSpain
  2. 2.Microbiology UnitHospital Xeral-CaldeLugoSpain
  3. 3.Infectious Disease UnitHospital Arquitecto MacideFerrolSpain

Personalised recommendations